SIRT3 and Melnick-Needles syndrome: Additionally, C12 treatment led to a reduction in mitochondrial ROS levels (Supplementary Fig. 5i), suggesting that SIRT3 activation also promotes the activation of antioxidant defenses in ALS MNs.